PG GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Procter & Gamble Company
Exchange: NYSESector: Consumer DefensiveIndustry: Household & Personal Products
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.
Did you know?
Price sits at 29% of its 52-week range.
Current Price
$145.71
+2.00%GoodMoat Value
$122.70
15.8% overvaluedProfile
Valuation (TTM)
Market Cap$340.49B
P/E20.69
EV$362.28B
P/B6.55
Shares Out2.34B
P/Sales3.99
Revenue$85.26B
EV/EBITDA15.02
Procter & Gamble Company (PG) Quality Analysis
PG Profitability
Profitability trend analysis coming soon
PG Growth
Growth trend analysis coming soon
PG Financial Health
Financial health indicators coming soon
PG Quality & Fundamental Analysis
Procter & Gamble Company (PG) is a Consumer Defensive company in the Household & Personal Products industry, listed on NYSE. This quality analysis page evaluates Procter & Gamble Company's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Procter & Gamble Company has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 19.30% and a return on equity (ROE) of 31.63%. Return on assets (ROA) stands at 13.14%.
The debt-to-equity ratio is 0.66, with a current ratio of 0.70. Operating margin is 24.26%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Procter & Gamble Company is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.